SCHEMBL19082063

SCHEMBL19082063

c1ccc2c(-c3c4ccccc4c(-c4ccc5cc(-c6cc7oc8c9ccccc9ccc8c7c7sc8ccccc8c67)ccc5c4)c4ccccc34)cccc2c1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 3/20 0.36
CYP1B1 Q16678 3/20 0.36
ALOX5 P09917 1/20 0.34
S1PR5 Q9H228 8/20 0.34
S1PR4 O95977 6/20 0.34
ESR2 Q92731 2/20 0.33
PRKDC P78527 1/20 0.33
ESR1 P03372 1/20 0.33
IKBKB O14920 1/20 0.32
CYP1A2 P05177 2/20 0.31
ABCB1 P08183 1/20 0.31
ABCC1 P33527 1/20 0.31
ABCG2 Q9UNQ0 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081938 0.94 ESR2 (0.34) CYP1A1CYP1B1ALOX5ESR2PRKDC
SCHEMBL19081796 0.91 ESR2 (0.37) CYP1A1CYP1B1ESR2PRKDCESR1
SCHEMBL19081846 0.90 CYP1A1 (0.38) CYP1A1CYP1B1S1PR5S1PR4ESR2
SCHEMBL19081921 0.89 CYP1A1 (0.37) CYP1A1CYP1B1ESR2PRKDCESR1
SCHEMBL19082067 0.87 S1PR5 (0.37) ALOX5S1PR5S1PR4ESR2PRKDC
SCHEMBL19081901 0.86 CYP1A1 (0.38) CYP1A1CYP1B1ESR2PRKDCESR1
SCHEMBL17945735 0.86 ALOX5 (0.39) CYP1A1CYP1B1ALOX5S1PR5S1PR4
SCHEMBL19076795 0.86 ALOX5 (0.39) CYP1A1CYP1B1ALOX5S1PR5S1PR4
SCHEMBL19081829 0.85 CYP1A1 (0.38) CYP1A1CYP1B1ESR2PRKDCESR1
SCHEMBL19081782 0.85 CYP1A1 (0.39) CYP1A1CYP1B1ESR2PRKDCESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885ALOX5 1939/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885ALOX5 1939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.